JUICEWORKS Exhibits and PredictMedix join forces to provide safe entry solutions to businesses throughout North America

Entry solutions Toronto 2

Toronto, Ontario – Award-winning Canadian fabricator, JUICEWORKS Exhibits (JUICEWORKS) has partnered with healthcare technology leader PredictMedix Inc. (CSE:PMED, OTCQB:PMEDF) to offer safe entry solutions to businesses, government institutions, schools and virtually any venue across North America.

As the economy starts to re-open, organizations everywhere are looking for safe entry solutions for their employees, customers, visitors and students. “Whether it’s visiting a loved one in a care home, going to work or shopping for groceries, we know that peace of mind is key.” says Jonathan Auger, President.
Determined to be part of the solution, JUICEWORKS formed a strategic partnership with PredictMedix, leveraging their proven, science-led AI that instantaneously screens individuals for a group of COVID-19 symptoms. Using a simple green light, red light approach, individuals can be safely and non-invasively screened in seconds.

“When it comes to our technology, it’s really a tool for mass screening. We’re talking about using multispectral cameras which can communicate to our proprietary AI algorithms and the AI algorithms can pick up on signs of COVID-19. Moreover, when we say signs, we are not talking about just fever, we are talking about additional symptoms like coughing, headache, exhaustion and a host of other parameters for which we have designed our technology. Because at the end of the day, when you’re talking about any space which has a large movement of people such as healthcare facilities, airports, schools, shopping malls, arenas, you need a mass screening tool to quickly identify those who have the most likelihood of having COVID-19, so you can isolate, limit spread and reduce the risk of the next pandemic.“ explains Dr. Rahul Kushwah, COO of PredictMedix, Inc.

Utilizing the PredictMedix AI, JUICEWORKS is offering safe indoor/outdoor entry solutions using temporary structure solutions. Outdoor entries include contactless doors, UV lamps for sterilization of personal items, air conditioning and safe air ventilation. Indoor entry solutions offer a non-invasive footprint which can be quickly assembled in lobbies, before occupants proceed further into the building. The technology also supports the option to screen for mask compliance, where it’s a mandatory requirement.


“Knowing the AI was already being used in international markets and was backed by an incredible group of experts made this a natural partnership for us. Whether you are an organization looking to protect your employees, or a shopping centre seeking the safest way to re-engage with your customers, this solution offers peace of mind. We are mindful of how difficult this whole situation has been on people and feel lucky to be able to contribute to making it a little easier as we all assimilate to our new normal.” says Auger.

For more information, please contact:

Tifany Scifo, Director of Sales & Marketing
647-285-5745 |

Founded in 1995 by Jonathan Auger, JUICEWORKS Exhibits began as a one-man team, servicing the exhibit marketing industry as an installer. Forging relationships at every turn, while consistently providing excellent customer service, Jon quickly earned the respect of clients and industry peers. This ultimately resulted in a substantial client increase and agency partners throughout North America. Today, with 2 North American locations (Toronto, Las Vegas), JUICEWORKS continues to deliver award-winning projects.

Their exponential growth is evident in being recognized by Growth 500 as one of Canada’s fastest growing companies 3 years running as well as Lenovo’s small business of the year award for 2019. Their customer-centric business model is built on hard work, communication and a dedicated team, committed to upholding the core values exhibited by its Founder and President. JUICEWORKS is acknowledged by clients globally as the go-to supplier for innovative design, quality craftsmanship and production. They have grown to represent some of the world’s most recognized cross-sector brands.

Their offerings include commercial/retail space design and production, pop-up shops, custom exhibit/event fabrication, experiential marketing, mobile marketing initiatives, museums and general contracting for events. Regardless of the task, their diverse team of experts take each project through concept to successful execution. Their primary goal is to continually win their client’s respect and approval on a job well done. To find out more visit


About PredictMedix Inc.

PredictMedix an artificial intelligence (“AI”) company developing disruptive tools for impairment testing and healthcare. It is intended that the Company’s cannabis and alcohol impairment detection tools will be used across various workplaces and by law enforcement agents. Its technology uses facial and voice recognition to identify both cannabis and alcohol impairment by utilizing multiple features along with numerous different data points. Testing does not require any body fluids or human intervention, thereby helping to remove human error and the potential for discrimination and prejudice.

The Company has partnered with Tech Mahindra and Hindalco to help expedite the launch of its impairment technology, as well as the prestigious Indian Institute of Technology.
The Company is also developing AI based screening for the healthcare industry. The recent advent of COVID-19 pandemic has placed unprecedented stress on the global economy and highlights the need for tools to help screen mass populations for infectious diseases, with the hope of preventing pandemics in the future. In turn, PredictMedix expanding its proprietary AI technology to screen for infectious diseases such as influenza and coronaviruses (COVID-19). Our current partners along with advisory board members have played a key role in gathering data pertaining to COVID-19, which has allowed us to develop a predictive mass screening tool for COVID-19. The technology is for mass screening and is to be used to predict and identify individuals who have the highest likelihood of being infected with COVID-19.

Additionally, psychiatric disorders such as depression, dementia and Alzheimer’s disease can carry a significant burden and early identification is the key to better management. To help address this, the Company is also expanding its proprietary AI technology to screen for psychiatric and/or brain disorders such as depression, dementia and Alzheimer’s disease. To find out more visit us at

Source: PredictMedix, Inc.